Shaily Engineering Plastics
- Market cap
- ₹ 13,594 Cr.
- P/E
- 79.4x
- P/B
- 19.15x
- 52-week range
- 1,770.9 – 3,615.2
- ROE
- 28%
- ROCE
- 30%
- Dividend yield
- 0.1%
- Debt / equity
- 0.25
- Sector
- Consumer Durables
- Industry
- Plastic Products - Consumer
- Listed on
- NSE, BSE
About
Shaily Engineering Plastics Limited is an exporter of engineering plastics components. The Company is engaged in the manufacture and sale of customized components made up of plastic and other materials. It manufactures value-added products from engineering plastics that find application in sectors such as consumer-home furnishings, medical devices, fast-moving consumer goods (FMCG), pharma packaging, automotive, consumer electronics, and others. Its diversified business platform includes Healthcare, Consumer, and Industrial. Its healthcare division has developed a portfolio of medical and drug delivery injectable devices, including pen injectors, auto-injectors, wearable injectors, and other specialty devices. Its consumer division consists of home furnishings, FMCG packaging, light-emitting diode lights, toys and carbon-steel furniture segments. Its industrial division comprises automotive components, appliances and high-performance engineering components.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Plastic Products - Consumer: 15 companies →Shaily Engineering Plastics against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)79.4 against a typical 25.6: pricier than most peers (1st = cheapest).13th of 15
- Sales growth+22.2% against a typical +2.4% from a year earlier.1st of 13
- Profit growth+44.4% against a typical −11.3% from a year earlier.3rd of 12
- Share price, 3 months−0.1% against a typical −10%.4th of 14
- Size₹ 13,594.4 Cr. market value against a typical ₹ 150.7 Cr. (1st = largest).1st of 12
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | — | Stable | 6 Oct 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 6 Oct 2026 | ▲ Upgrade1 notch | — | Low | CARE | ₹ 35 Cr. | |
| 9 Oct 2025 | Reaffirmed | CARE A+ | — | CARE | ₹ 274.62 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 29 Oct 2026Upcoming | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2026 and other business matters |
| 19 May 2026 | Financial Results/Dividend/Fund Raising/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, dividend, Fund Raising and other business matters |
| 12 Feb 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2025 and other business matters |
| 8 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 11 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
| 13 May 2025 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters |
| 8 Feb 2025 | Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 156 | 145 | 163 | 169 | 180 | 186 | 203 | 225 | 236 | 236 | 224 | 275 |
| Expenses | 133 | 124 | 135 | 142 | 148 | 148 | 155 | 164 | 168 | 173 | 161 | 189 |
| Operating Profit | 23 | 21 | 28 | 27 | 31 | 38 | 48 | 61 | 68 | 64 | 63 | 86 |
| OPM % | 14% | 15% | 17% | 16% | 17% | 20% | 24% | 27% | 29% | 27% | 28% | 31% |
| Other Income | 3 | 1 | 2 | 1 | 1 | 0 | 5 | 2 | 2 | 0 | 14 | 0 |
| Interest | 4 | 5 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Depreciation | 8 | 9 | 9 | 10 | 10 | 10 | 10 | 11 | 11 | 12 | 12 | 13 |
| Profit before tax | 13 | 8 | 16 | 14 | 18 | 24 | 38 | 48 | 55 | 48 | 61 | 70 |
| Tax % | 25% | 24% | 27% | 30% | 26% | 26% | 23% | 25% | 25% | 25% | 20% | 25% |
| Net Profit | 10 | 6 | 11 | 10 | 13 | 18 | 30 | 36 | 41 | 36 | 49 | 52 |
| EPS in Rs | 2.15 | 1.36 | 2.48 | 2.13 | 2.93 | 3.95 | 6.43 | 7.83 | 8.93 | 7.76 | 10.59 | 11.41 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 15%
- 5 Years
- 21%
- 3 Years
- 15%
- TTM
- 22%
- 10 Years
- 28%
- 5 Years
- 49%
- 3 Years
- 75%
- TTM
- 83%
- 10 Years
- 41%
- 5 Years
- 56%
- 3 Years
- 114%
- TTM
- —
- 10 Years
- 16%
- 5 Years
- 16%
- 3 Years
- 19%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Shaily Engineering Plastics | ₹ 3,040.00 | ₹ 13,594 Cr. | 79.4x | 19.2x | 28% | — |
| Gujarat Fluorochemicals | ₹ 4,241.25 | ₹ 47,986 Cr. | 77.4x | 5.8x | 7.7% | 11.5% |
| DCM Shriram | ₹ 962.10 | ₹ 14,996 Cr. | 5.6x | 2.1x | 11.6% | 6% |
| Supreme Petrochem | ₹ 710.10 | ₹ 13,338 Cr. | 38.7x | 5.5x | 14.3% | 6.1% |
| Styrenix Performance Materials | ₹ 1,944.00 | ₹ 3,417 Cr. | 21.2x | 2.9x | 14.7% | 5.4% |
| Ganesha Ecosphere | ₹ 987.50 | ₹ 2,642 Cr. | 83.1x | 2.5x | 3.2% | 2.6% |
Management
- Mahendra Bhogilal Sanghvi
- Executive Chairman of the Board
- Paresh Jain
- Chief Financial Officer
- Harish Govind Punwani
- Company Secretary and Compliance Officer
- Amit Mahendra Sanghvi
- Managing Director, Executive Director
- Laxman Bhogilal Sanghvi
- Executive Director
- Tilottama Mahendra Sanghvi
- Whole-Time Director
- Chi Hung Kam
- Chief Operating Officer - Healthcare
- Sanjay Shah
- Chief Strategy Officer
Prices are delayed and for information only. Nothing on this page is investment advice.